NC
DCPH

Nexthera Capital’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Nexthera Capital’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-42,865
Closed -$995K – 31
2019
Q1 		$995K Sell
42,865
-79,027
-65% -$2.07M 1.21% 21
2018
Q4 		$2.56M Buy
121,892
+91,270
+298% +$2.24M 1.05% 17
2018
Q3 		$1.19M Sell
30,622
-99,178
-76% -$3.66M 0.23% 43
2018
Q2 		$5.11M Buy
+129,800
New +$3.82M 0.79% 29

Other funds holding DCPH

NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nexthera Capital's DCPH Position: Q2 2019 in Review

Nexthera Capital sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2019, closing a stake of 42,865 shares — an estimated $995K sold.

Nexthera Capital first reported a position in DCPH in Q2 2018 and held it in 4 quarters. The position peaked at $5.11M in Q2 2018. 85 funds tracked by Wall St. Rank hold DCPH as of Q2 2019.

  • Nexthera Capital reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • Nexthera Capital sold 42,865 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2019, an estimated $995K.
  • Nexthera Capital first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q2 2018 and held it in 4 quarters.
  • Nexthera Capital's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $5.11M in Q2 2018.
  • 85 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2019.

Based on Nexthera Capital's 13F filing for Q2 2019, filed 14 Aug 2019.